VeriChip Corporation Protects More Than One Million Infants in 2007
12 2월 2008 - 11:00PM
Business Wire
VeriChip Corporation (�Company�) (NASDAQ:CHIP), a provider of Radio
Frequency Identification (RFID) systems for healthcare and
patient-related needs, announced today that Xmark�s infant
protection systems, led by systems sold under the HUGS� brand,
protected more than one million infants born in hospitals in 2007.
Xmark is a wholly owned subsidiary of VeriChip. Daniel A. Gunther,
President and CEO of Xmark, said, �Now more than ever, hospitals
value the security our infant protection systems bring to their
labor and delivery wards. As the leader in this industry, we are
proud to protect hospitals� smallest and most vulnerable patients.
We see sustained growth of this business in 2008 and beyond as we
continue to expand our reach throughout North America and other
parts of the world where these systems are less common yet no less
important.� Xmark�s infant protection systems are designed to
prevent infant abductions and inadvertent child mismatching in
hospitals. The main component of the systems is a wearable RFID tag
that is assigned to child and mother following birth. Monitors
positioned throughout the hospital detect the integrity of the tags
and location of the child. If a newborn is removed from the ward,
if the tag is lifted from the baby�s skin or if the ankle strap is
compromised, the system immediately triggers an alarm, alerting
hospital security to the situation. Xmark infant protection systems
also protect against mismatching events by affixing matching RFID
tags to mother and child. If the mother is given the wrong child,
the RFID tag detects the mismatch and activates an audible alarm.
For more information on Xmark�s products, please contact
1-866-55�XMARK or email sales@xmark.com. Additional information can
be found online at www.xmark.com. About Xmark Based in Ottawa,
Ontario, Xmark is a wholly owned subsidiary of VeriChip
Corporation. For over 25 years, Xmark Corporation has provided RFID
solutions to identify, locate, and protect people and assets in
healthcare environments. Its market-leading infant protection,
wander prevention, personal duress, and asset tracking applications
are trusted by over 5,000 healthcare institutions worldwide to keep
individuals safe. Xmark products are installed and serviced through
an international network of authorized dealers, backed by a
dedicated technical services department at Xmark. All aspects of
Xmark�s business are certified to the ISO 9001 quality standard.
About VeriChip VeriChip Corporation, headquartered in Delray Beach,
Florida, develops, markets and sells RFID systems used to identify,
locate and protect people and assets. VeriChip's goal is to become
the leading provider of RFID systems for people in the healthcare
industry. The Company recently began marketing its VeriMed(TM)
Patient Identification System, a passive RFID system for rapidly
and accurately identifying people who arrive in an emergency room
and are unable to communicate. This system uses the first
human-implantable passive RFID microchip, the implantable
VeriChip(TM), cleared for medical use in October 2004 by the U.S.
FDA. For more information on VeriChip, please call 1-800-970-2447,
or email info@verichipcorp.com. Additional information can be found
online at http://www.verichipcorp.com. Statements about the
Company's future expectations, including growth of the business,
future revenues and earnings, and all other statements in this
press release other than historical facts are "forward-looking
statements" within the meaning of Section 27A of the Securities Act
of 1933, Section 21E of the Securities Exchange Act of 1934, and as
that term is defined in the Private Litigation Reform Act of 1995.
Such forward-looking statements involve risks and uncertainties and
are subject to change at any time, and the Company's actual results
could differ materially from expected results. Information about
factors that could affect the Company�s business is set forth in
the Company�s various filings with the Securities and Exchange
Commission, including those set forth in the Company�s 10-K filed
on April�2, 2007, under the caption �Risk Factors.� The Company
undertakes no obligation to update or release any revisions to
these forward-looking statements to reflect events or circumstances
after the date of this statement or to reflect the occurrence of
unanticipated events, except as required by law.
Verichip (MM) (NASDAQ:CHIP)
과거 데이터 주식 차트
부터 6월(6) 2024 으로 7월(7) 2024
Verichip (MM) (NASDAQ:CHIP)
과거 데이터 주식 차트
부터 7월(7) 2023 으로 7월(7) 2024